Peromyscus maniculatus bairdii isolate BW chromosome 15, HU_Pman_2.1.3, whole genome shotgun sequence.
Peromyscus maniculatus bairdii (prairie deer mouse)
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Cricetidae; Neotominae; Peromyscus.
REFSEQ INFORMATION: The reference sequence is identical to\nCM010893.2.\nAssembly name: HU_Pman_2.1.3\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Harvard University / Howard\nHughes Medical Institute on 2020/09/17. The original whole-genome\nshotgun project has the accession RCWR00000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Harvard University / Howard Hughes\n Medical Institute\nAssembly Method :: AllPaths v. 2016-03\nAssembly Name :: HU_Pman_2.1.3\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 115.0x\nSequencing Technology :: Illumina HiSeq\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Peromyscus maniculatus bairdii\n Annotation Release 102\nAnnotation Version :: 102\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
zinc finger protein 431-like, transcript variant X3
COORDINATES: polyA evidence [ECO:0006239]
zinc finger protein 431-like, transcript variant X2
zinc finger protein 431-like, transcript variant X1
leucine-rich repeat-containing protein 14B
coiled-coil domain containing 127, transcript variant X2
coiled-coil domain containing 127, transcript variant X1
coiled-coil domain-containing protein 127
succinate dehydrogenase complex flavoprotein subunit A
succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial
programmed cell death 6, transcript variant X1
programmed cell death 6, transcript variant X2
programmed cell death protein 6 isoform X1
programmed cell death protein 6 isoform X2
exocyst complex component 3, transcript variant X1
exocyst complex component 3, transcript variant X2
solute carrier family 9 member A3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
solute carrier family 9 member A3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
solute carrier family 9 member A3, transcript variant X2
solute carrier family 9 member A3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
solute carrier family 9 member A3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
solute carrier family 9 member A3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
centrosomal protein 72, transcript variant X4
centrosomal protein 72, transcript variant X2
centrosomal protein 72, transcript variant X3
centrosomal protein 72, transcript variant X1
centrosomal protein of 72 kDa isoform X2
centrosomal protein of 72 kDa isoform X1
tubulin polymerization promoting protein, transcript variant X1
tubulin polymerization promoting protein, transcript variant X2
tubulin polymerization-promoting protein
palmitoyltransferase ZDHHC11, transcript variant X1
palmitoyltransferase ZDHHC11, transcript variant X2
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
bromodomain containing 9, transcript variant X3
bromodomain containing 9, transcript variant X2
bromodomain containing 9, transcript variant X1
bromodomain-containing protein 9 isoform X3
bromodomain-containing protein 9 isoform X2
bromodomain-containing protein 9 isoform X1
uncharacterized LOC121822882, transcript variant X2
uncharacterized LOC121822882, transcript variant X1
NKD inhibitor of WNT signaling pathway 2
solute carrier family 12 member 7, transcript variant X2
solute carrier family 12 member 7, transcript variant X1
solute carrier family 12 member 7, transcript variant X3
solute carrier family 12 member 7, transcript variant X4
solute carrier family 12 member 7 isoform X2
solute carrier family 12 member 7 isoform X1
solute carrier family 12 member 7 isoform X4
solute carrier family 12 member 7 isoform X3
40S ribosomal protein S2-like, transcript variant X2
40S ribosomal protein S2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 mRNAs, 1 EST, 10 Proteins, and 39% coverage of the annotated genomic feature by RNAseq alignments
sodium-dependent neutral amino acid transporter B(0)AT1
solute carrier family 6 member 18, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 36% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 6 member 18, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 32% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 6 member 18, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 29% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 6 member 18, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 25% coverage of the annotated genomic feature by RNAseq alignments
inactive sodium-dependent neutral amino acid transporter B(0)AT3 isoform X1
inactive sodium-dependent neutral amino acid transporter B(0)AT3 isoform X2
inactive sodium-dependent neutral amino acid transporter B(0)AT3 isoform X3
inactive sodium-dependent neutral amino acid transporter B(0)AT3 isoform X4
telomerase reverse transcriptase, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
telomerase reverse transcriptase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
telomerase reverse transcriptase isoform X2
telomerase reverse transcriptase, transcript variant X3
telomerase reverse transcriptase, transcript variant X1
telomerase reverse transcriptase isoform X1
cleft lip and palate transmembrane protein 1-like protein isoform X2
cleft lip and palate transmembrane protein 1-like protein isoform X1
solute carrier family 6 member 3, transcript variant X2
solute carrier family 6 member 3, transcript variant X1
sodium-dependent dopamine transporter isoform X1
sodium-dependent dopamine transporter isoform X2
lysophosphatidylcholine acyltransferase 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
mitochondrial ribosomal protein L36, transcript variant X2
mitochondrial ribosomal protein L36, transcript variant X1
mitochondrial ribosomal protein L36, transcript variant X3
39S ribosomal protein L36, mitochondrial
NADH:ubiquinone oxidoreductase subunit S6
NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial
iroquois homeobox 4, transcript variant X1
iroquois homeobox 4, transcript variant X2
iroquois-class homeodomain protein IRX-4
uncharacterized LOC121822907, transcript variant X2
uncharacterized LOC121822907, transcript variant X1
uncharacterized LOC121822907, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 5 bases in 3 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 5 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: iroquois-class homeodomain protein IRX-2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
iroquois-class homeodomain protein IRX-1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 65% coverage of the annotated genomic feature by RNAseq alignments
ADAM metallopeptidase with thrombospondin type 1 motif 16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: A disintegrin and metalloproteinase with thrombospondin motifs 16
interactor of little elongation complex ELL subunit 1, transcript variant X1
little elongation complex subunit 1 isoform X1
interactor of little elongation complex ELL subunit 1, transcript variant X2
little elongation complex subunit 1 isoform X2
uncharacterized LOC121822684, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC121822684, transcript variant X3
uncharacterized LOC121822684, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 83 samples with support for all annotated introns
uncharacterized LOC121822888, transcript variant X1
uncharacterized LOC121822888, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC121822888, transcript variant X2
uncharacterized LOC102924883, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC102924883, transcript variant X2
mediator of RNA polymerase II transcription subunit 10
ubiquitin conjugating enzyme E2 Q family like 1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: ubiquitin-conjugating enzyme E2Q-like protein 1
RNA cytosine C(5)-methyltransferase NSUN2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 72 samples with support for all annotated introns
uncharacterized LOC121822687, transcript variant X2
uncharacterized LOC121822687, transcript variant X1
terminal nucleotidyltransferase 4A, transcript variant X2
terminal nucleotidyltransferase 4A, transcript variant X4
terminal nucleotidyltransferase 4A, transcript variant X1
terminal nucleotidyltransferase 4A, transcript variant X3
terminal nucleotidyltransferase 4A isoform X1
terminal nucleotidyltransferase 4A isoform X2
adenylate cyclase 2, transcript variant X1
adenylate cyclase 2, transcript variant X2
FAST kinase domains 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 52 samples with support for all annotated introns
FAST kinase domains 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
FAST kinase domains 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 62 samples with support for all annotated introns
FAST kinase domains 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
FAST kinase domain-containing protein 3, mitochondrial isoform X1
FAST kinase domains 3, transcript variant X5
FAST kinase domain-containing protein 3, mitochondrial isoform X2
5-methyltetrahydrofolate-homocysteine methyltransferase reductase, transcript variant X3
5-methyltetrahydrofolate-homocysteine methyltransferase reductase, transcript variant X2
5-methyltetrahydrofolate-homocysteine methyltransferase reductase, transcript variant X6
5-methyltetrahydrofolate-homocysteine methyltransferase reductase, transcript variant X1
5-methyltetrahydrofolate-homocysteine methyltransferase reductase, transcript variant X4
5-methyltetrahydrofolate-homocysteine methyltransferase reductase, transcript variant X5
methionine synthase reductase isoform X1
methionine synthase reductase isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF01299
zinc finger protein 58, transcript variant X1
zinc finger protein 58, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments
zinc finger protein 58-like, transcript variant X4
zinc finger protein 58-like, transcript variant X7
zinc finger protein 58-like, transcript variant X5
zinc finger protein 58-like, transcript variant X1
zinc finger protein 58-like, transcript variant X6
zinc finger protein 58-like, transcript variant X2
zinc finger protein 58-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: protein PIMREG-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: zinc finger protein 420-like
zinc finger protein 93-like, transcript variant X2
zinc finger protein 93-like, transcript variant X1
zinc finger protein 93-like, transcript variant X3
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: zinc finger protein 58-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
adenylosuccinate synthetase isozyme 2-like
LOW QUALITY PROTEIN: adenylosuccinate synthetase isozyme 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
LOW QUALITY PROTEIN: zinc finger protein 728-like
zinc finger protein 714-like, transcript variant X1
zinc finger protein 714-like, transcript variant X2
zinc finger protein 420-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
zinc finger protein 420-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zinc finger protein 420-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
zinc finger protein 420-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
zinc finger protein 420-like, transcript variant X2
zinc finger protein 420-like, transcript variant X6
zinc finger protein 420-like, transcript variant X9
zinc finger protein 420-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
zinc finger protein 420-like, transcript variant X1
uncharacterized LOC107401564, transcript variant X4
uncharacterized LOC107401564, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC107401564, transcript variant X3
uncharacterized LOC107401564, transcript variant X2
uncharacterized LOC121822689, transcript variant X3
uncharacterized LOC121822689, transcript variant X2
uncharacterized LOC121822689, transcript variant X7
uncharacterized LOC121822689, transcript variant X5
uncharacterized LOC121822689, transcript variant X6
uncharacterized LOC121822689, transcript variant X4
uncharacterized LOC121822689, transcript variant X8
uncharacterized LOC121822689, transcript variant X9
uncharacterized LOC121822689, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC121822692, transcript variant X2
uncharacterized LOC121822692, transcript variant X1
COORDINATES: nucleotide motif:Rfam:12.0:RF01156
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 15% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 73% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 91% coverage of the annotated genomic feature by RNAseq alignments
ATP synthase c subunit lysine N-methyltransferase
ATP synthase subunit C lysine N-methyltransferase
carboxymethylenebutenolidase homolog, transcript variant X1
carboxymethylenebutenolidase homolog, transcript variant X2
carboxymethylenebutenolidase homolog, transcript variant X4
carboxymethylenebutenolidase homolog, transcript variant X3
membrane associated ring-CH-type finger 6, transcript variant X1
membrane associated ring-CH-type finger 6, transcript variant X2
E3 ubiquitin-protein ligase MARCHF6 isoform X2
E3 ubiquitin-protein ligase MARCHF6 isoform X1
membrane associated ring-CH-type finger 6, transcript variant X3
E3 ubiquitin-protein ligase MARCHF6 isoform X3
rhophilin associated tail protein 1 like
ankyrin repeat domain 33B, transcript variant X2
ankyrin repeat domain 33B, transcript variant X1
ankyrin repeat domain-containing protein 33B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
non-histone chromosomal protein HMG-14-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 58% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 19% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 8 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
trio Rho guanine nucleotide exchange factor
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: triple functional domain protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
OTU deubiquitinase with linear linkage specificity like, transcript variant X1
OTU deubiquitinase with linear linkage specificity like, transcript variant X2
inactive ubiquitin thioesterase OTULINL isoform X1
inactive ubiquitin thioesterase OTULINL isoform X2
OTU deubiquitinase with linear linkage specificity, transcript variant X1
OTU deubiquitinase with linear linkage specificity, transcript variant X3
OTU deubiquitinase with linear linkage specificity, transcript variant X2
ubiquitin thioesterase otulin isoform X1
ubiquitin thioesterase otulin isoform X2
ubiquitin thioesterase otulin isoform X3
ANKH inorganic pyrophosphate transport regulator
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 20% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 4% coverage of the annotated genomic feature by RNAseq alignments
membrane associated ring-CH-type finger 11, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
membrane associated ring-CH-type finger 11, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
E3 ubiquitin-protein ligase MARCHF11 isoform X1
E3 ubiquitin-protein ligase MARCHF11 isoform X2
reticulophagy regulator 1, transcript variant X1
reticulophagy regulator 1, transcript variant X2
reticulophagy regulator 1, transcript variant X3
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC121822708, transcript variant X2
uncharacterized LOC121822708, transcript variant X1
brain abundant membrane attached signal protein 1, transcript variant X1
brain abundant membrane attached signal protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 10% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
uncharacterized LOC121822896, transcript variant X2
uncharacterized LOC121822896, transcript variant X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00419
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC121822898, transcript variant X2
uncharacterized LOC121822898, transcript variant X3
uncharacterized LOC121822898, transcript variant X1
plasminogen activator inhibitor 1 RNA-binding protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
drosha ribonuclease III, transcript variant X2
drosha ribonuclease III, transcript variant X3
drosha ribonuclease III, transcript variant X1
drosha ribonuclease III, transcript variant X4
myotubularin related protein 12, transcript variant X1
myotubularin related protein 12, transcript variant X2
myotubularin related protein 12, transcript variant X3
myotubularin-related protein 12 isoform X1
myotubularin-related protein 12 isoform X2
myotubularin-related protein 12 isoform X3
zinc finger RNA binding protein, transcript variant X3
zinc finger RNA binding protein, transcript variant X1
zinc finger RNA binding protein, transcript variant X4
zinc finger RNA binding protein, transcript variant X2
zinc finger RNA-binding protein isoform X4
zinc finger RNA-binding protein isoform X3
zinc finger RNA-binding protein isoform X1
zinc finger RNA-binding protein isoform X2
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA lysine (anticodon CUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
activated RNA polymerase II transcriptional coactivator p15
natriuretic peptide receptor 3, transcript variant X1
natriuretic peptide receptor 3, transcript variant X2
atrial natriuretic peptide receptor 3 isoform X1
atrial natriuretic peptide receptor 3 isoform X2
ADAM metallopeptidase with thrombospondin type 1 motif 12
A disintegrin and metalloproteinase with thrombospondin motifs 12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
solute carrier family 45 member 2, transcript variant X1
solute carrier family 45 member 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
C1q and TNF related 3, transcript variant X2
C1q and TNF related 3, transcript variant X1
complement C1q tumor necrosis factor-related protein 3 isoform X2
complement C1q tumor necrosis factor-related protein 3 isoform X1
uncharacterized LOC121822719, transcript variant X2
uncharacterized LOC121822719, transcript variant X3
uncharacterized LOC121822719, transcript variant X8
uncharacterized LOC121822719, transcript variant X4
uncharacterized LOC121822719, transcript variant X6
uncharacterized LOC121822719, transcript variant X9
uncharacterized LOC121822719, transcript variant X7
uncharacterized LOC121822719, transcript variant X1
uncharacterized LOC121822719, transcript variant X5
transfer RNA asparagine (anticodon AUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 69% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC121822721, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC121822721, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC121822721, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC121822721, transcript variant X3
retinoic acid induced 14, transcript variant X2
retinoic acid induced 14, transcript variant X3
retinoic acid induced 14, transcript variant X1
retinoic acid induced 14, transcript variant X4
retinoic acid induced 14, transcript variant X5
retinoic acid induced 14, transcript variant X6
tetratricopeptide repeat domain 23 like, transcript variant X2
tetratricopeptide repeat domain 23 like, transcript variant X1
tetratricopeptide repeat protein 23-like isoform X1
tetratricopeptide repeat protein 23-like isoform X2
RAD1 checkpoint DNA exonuclease, transcript variant X1
RAD1 checkpoint DNA exonuclease, transcript variant X3
RAD1 checkpoint DNA exonuclease, transcript variant X2
ribosome biogenesis protein BRX1 homolog
DnaJ heat shock protein family (Hsp40) member C21
alanine--glyoxylate aminotransferase 2, mitochondrial-like
alanine--glyoxylate aminotransferase 2, mitochondrial, transcript variant X1
alanine--glyoxylate aminotransferase 2, mitochondrial, transcript variant X2
alanine--glyoxylate aminotransferase 2, mitochondrial isoform X2
alanine--glyoxylate aminotransferase 2, mitochondrial isoform X1
prolactin receptor, transcript variant X12
prolactin receptor, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
prolactin receptor, transcript variant X8
prolactin receptor, transcript variant X2
prolactin receptor, transcript variant X9
prolactin receptor, transcript variant X5
prolactin receptor, transcript variant X7
prolactin receptor, transcript variant X4
prolactin receptor, transcript variant X3
prolactin receptor, transcript variant X1
prolactin receptor, transcript variant X6
prolactin receptor, transcript variant X11
prolactin receptor, transcript variant X10
uncharacterized LOC107402990, transcript variant X6
uncharacterized LOC107402990, transcript variant X5
uncharacterized LOC107402990, transcript variant X7
uncharacterized LOC107402990, transcript variant X2
uncharacterized LOC107402990, transcript variant X3
uncharacterized LOC107402990, transcript variant X1
uncharacterized LOC107402990, transcript variant X4
sperm flagellar 2, transcript variant X4
sperm flagellar 2, transcript variant X2
sperm flagellar 2, transcript variant X3
sperm flagellar 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC121822724, transcript variant X2
uncharacterized LOC121822724, transcript variant X1
calcyphosine like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
calcyphosine like, transcript variant X1
UDP-glucuronosyltransferase 3A2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
UDP-glucuronosyltransferase 3A2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
UDP-glucuronosyltransferase 3A2-like isoform X2
UDP-glucuronosyltransferase 3A2-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 37 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00619
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 435 Proteins, and 17% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00007
T-complex protein 1 subunit epsilon-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 63% coverage of the annotated genomic feature by RNAseq alignments
G-protein coupled receptor-associated protein LMBRD2
NAD kinase 2, mitochondrial, transcript variant X2
NAD kinase 2, mitochondrial, transcript variant X1
NAD kinase 2, mitochondrial, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 91 samples with support for all annotated introns
RAN binding protein 3 like, transcript variant X3
RAN binding protein 3 like, transcript variant X1
RAN binding protein 3 like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
NIPBL cohesin loading factor, transcript variant X1
NIPBL cohesin loading factor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 9 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 49 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 39% coverage of the annotated genomic feature by RNAseq alignments
ciliogenesis and planar polarity effector 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 47% coverage of the annotated genomic feature by RNAseq alignments
nuclear pore complex protein Nup155-like, transcript variant X2
nuclear pore complex protein Nup155-like, transcript variant X1
nuclear pore complex protein Nup155-like
nuclear pore complex protein Nup155, transcript variant X1
nuclear pore complex protein Nup155, transcript variant X2
glial cell line-derived neurotrophic factor
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins
EGF like, fibronectin type III and laminin G domains, transcript variant X1
EGF like, fibronectin type III and laminin G domains, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 35% coverage of the annotated genomic feature by RNAseq alignments
EGF like, fibronectin type III and laminin G domains, transcript variant X5
EGF like, fibronectin type III and laminin G domains, transcript variant X4
EGF like, fibronectin type III and laminin G domains, transcript variant X3
LIF receptor subunit alpha, transcript variant X2
LIF receptor subunit alpha, transcript variant X1
uncharacterized LOC107401238, transcript variant X2
uncharacterized LOC107401238, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
oncostatin M receptor, transcript variant X5
oncostatin M receptor, transcript variant X3
oncostatin M receptor, transcript variant X1
oncostatin M receptor, transcript variant X2
oncostatin M receptor, transcript variant X4
oncostatin-M-specific receptor subunit beta isoform X1
oncostatin-M-specific receptor subunit beta isoform X2
oncostatin-M-specific receptor subunit beta isoform X4
oncostatin-M-specific receptor subunit beta isoform X3
RPTOR independent companion of MTOR complex 2, transcript variant X5
RPTOR independent companion of MTOR complex 2, transcript variant X4
RPTOR independent companion of MTOR complex 2, transcript variant X2
RPTOR independent companion of MTOR complex 2, transcript variant X3
RPTOR independent companion of MTOR complex 2, transcript variant X1
rapamycin-insensitive companion of mTOR isoform X4
rapamycin-insensitive companion of mTOR isoform X2
rapamycin-insensitive companion of mTOR isoform X3
rapamycin-insensitive companion of mTOR isoform X1
FYN binding protein 1, transcript variant X1
FYN binding protein 1, transcript variant X2
DAB adaptor protein 2, transcript variant X2
DAB adaptor protein 2, transcript variant X3
DAB adaptor protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 26% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC121822912, transcript variant X1
uncharacterized LOC121822912, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 13% coverage of the annotated genomic feature by RNAseq alignments
tetratricopeptide repeat domain 33, transcript variant X2
tetratricopeptide repeat domain 33, transcript variant X1
tetratricopeptide repeat domain 33, transcript variant X4
tetratricopeptide repeat domain 33, transcript variant X3
protein kinase AMP-activated catalytic subunit alpha 1, transcript variant X1
protein kinase AMP-activated catalytic subunit alpha 1, transcript variant X2
5'-AMP-activated protein kinase catalytic subunit alpha-1 isoform X1
5'-AMP-activated protein kinase catalytic subunit alpha-1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00577
caspase recruitment domain family member 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
caspase recruitment domain family member 6, transcript variant X2
caspase recruitment domain-containing protein 6 isoform X1
caspase recruitment domain-containing protein 6 isoform X2
maestro heat like repeat family member 2B, transcript variant X3
maestro heat like repeat family member 2B, transcript variant X2
maestro heat like repeat family member 2B, transcript variant X1
maestro heat-like repeat-containing protein family member 2B isoform X3
maestro heat-like repeat-containing protein family member 2B isoform X1
maestro heat-like repeat-containing protein family member 2B isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
phosphatidylinositol specific phospholipase C X domain containing 3
succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial
uncharacterized LOC121822740, transcript variant X1
uncharacterized LOC121822740, transcript variant X2
chromosome 15 C5orf51 homolog, transcript variant X1
chromosome 15 C5orf51 homolog, transcript variant X2
UPF0600 protein C5orf51 homolog isoform X1
UPF0600 protein C5orf51 homolog isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 13% coverage of the annotated genomic feature by RNAseq alignments
growth hormone receptor, transcript variant X5
growth hormone receptor, transcript variant X1
growth hormone receptor, transcript variant X6
growth hormone receptor, transcript variant X3
growth hormone receptor, transcript variant X2
growth hormone receptor, transcript variant X4
zinc finger protein 131, transcript variant X3
zinc finger protein 131, transcript variant X1
zinc finger protein 131, transcript variant X5
zinc finger protein 131, transcript variant X2
zinc finger protein 131, transcript variant X4
zinc finger protein 131, transcript variant X6
zinc finger protein 131, transcript variant X7
zinc finger protein 131, transcript variant X8
NIM1 serine/threonine protein kinase, transcript variant X2
NIM1 serine/threonine protein kinase, transcript variant X1
NIM1 serine/threonine protein kinase, transcript variant X3
serine/threonine-protein kinase NIM1 isoform X1
serine/threonine-protein kinase NIM1 isoform X2
3-hydroxy-3-methylglutaryl-CoA synthase 1, transcript variant X3
3-hydroxy-3-methylglutaryl-CoA synthase 1, transcript variant X4
3-hydroxy-3-methylglutaryl-CoA synthase 1, transcript variant X2
3-hydroxy-3-methylglutaryl-CoA synthase 1, transcript variant X1
hydroxymethylglutaryl-CoA synthase, cytoplasmic isoform X1
hydroxymethylglutaryl-CoA synthase, cytoplasmic isoform X2
uncharacterized LOC107402789, transcript variant X2
uncharacterized LOC107402789, transcript variant X1
uncharacterized LOC107402789, transcript variant X4
uncharacterized LOC107402789, transcript variant X3
uncharacterized LOC107402789, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
chromosome 15 C5orf34 homolog, transcript variant X3
chromosome 15 C5orf34 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
chromosome 15 C5orf34 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
poly(A) binding protein interacting protein 1, transcript variant X4
poly(A) binding protein interacting protein 1, transcript variant X3
poly(A) binding protein interacting protein 1, transcript variant X2
poly(A) binding protein interacting protein 1, transcript variant X1
polyadenylate-binding protein-interacting protein 1 isoform X2
polyadenylate-binding protein-interacting protein 1 isoform X1
polyadenylate-binding protein-interacting protein 1 isoform X3
nicotinamide nucleotide transhydrogenase, transcript variant X3
nicotinamide nucleotide transhydrogenase, transcript variant X4
nicotinamide nucleotide transhydrogenase, transcript variant X6
nicotinamide nucleotide transhydrogenase, transcript variant X2
nicotinamide nucleotide transhydrogenase, transcript variant X5
nicotinamide nucleotide transhydrogenase, transcript variant X1
NAD(P) transhydrogenase, mitochondrial isoform X1
NAD(P) transhydrogenase, mitochondrial isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00049
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 12% coverage of the annotated genomic feature by RNAseq alignments
39S ribosomal protein S30, mitochondrial
hyperpolarization activated cyclic nucleotide gated potassium channel 1
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 68% coverage of the annotated genomic feature by RNAseq alignments
poly(ADP-ribose) polymerase family member 8, transcript variant X2
poly(ADP-ribose) polymerase family member 8, transcript variant X1
protein mono-ADP-ribosyltransferase PARP8 isoform X1
protein mono-ADP-ribosyltransferase PARP8 isoform X2
transfer RNA alanine (anticodon AGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC121822746, transcript variant X1
uncharacterized LOC121822746, transcript variant X2
uncharacterized LOC121822746, transcript variant X3
microtubule-associated proteins 1A/1B light chain 3B-like
transcription elongation factor A protein-like 8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
pelota mRNA surveillance and ribosome rescue factor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 106 samples with support for all annotated introns
pelota mRNA surveillance and ribosome rescue factor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments
molybdenum cofactor synthesis 2, transcript variant X4
molybdopterin synthase catalytic subunit isoform X4
molybdenum cofactor synthesis 2, transcript variant X1
uncharacterized protein Mocs2 isoform X1
molybdenum cofactor synthesis 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
molybdenum cofactor synthesis 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized protein Mocs2 isoform X3
uncharacterized protein Mocs2 isoform X2
NADH:ubiquinone oxidoreductase subunit S4, transcript variant X1
NADH:ubiquinone oxidoreductase subunit S4, transcript variant X2
NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial isoform X2
NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial isoform X1
uncharacterized LOC121822749, transcript variant X2
uncharacterized LOC121822749, transcript variant X1
ADP ribosylation factor like GTPase 15, transcript variant X3
ADP ribosylation factor like GTPase 15, transcript variant X1
ADP ribosylation factor like GTPase 15, transcript variant X2
ADP ribosylation factor like GTPase 15, transcript variant X4
ADP-ribosylation factor-like protein 15 isoform X1
ADP-ribosylation factor-like protein 15 isoform X3
ADP-ribosylation factor-like protein 15 isoform X2
heat shock protein family B (small) member 3, transcript variant X1
heat shock protein family B (small) member 3, transcript variant X2
uncharacterized LOC121822754, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC121822754, transcript variant X2
uncharacterized LOC121822754, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 31% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
glutathione peroxidase 8 (putative), transcript variant X4
glutathione peroxidase 8 (putative), transcript variant X1
glutathione peroxidase 8 (putative), transcript variant X2
glutathione peroxidase 8 (putative), transcript variant X3
probable glutathione peroxidase 8 isoform X1
probable glutathione peroxidase 8 isoform X2
probable glutathione peroxidase 8 isoform X3
probable glutathione peroxidase 8 isoform X4
multiciliate differentiation and DNA synthesis associated cell cycle protein
DExH-box helicase 29, transcript variant X1
DExH-box helicase 29, transcript variant X2
ATP-dependent RNA helicase DHX29 isoform X1
ATP-dependent RNA helicase DHX29 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 95 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 38 member 9, transcript variant X2
solute carrier family 38 member 9, transcript variant X1
solute carrier family 38 member 9, transcript variant X9
solute carrier family 38 member 9, transcript variant X4
solute carrier family 38 member 9, transcript variant X6
solute carrier family 38 member 9, transcript variant X8
solute carrier family 38 member 9, transcript variant X7
solute carrier family 38 member 9, transcript variant X5
solute carrier family 38 member 9, transcript variant X3
sodium-coupled neutral amino acid transporter 9 isoform X1
sodium-coupled neutral amino acid transporter 9 isoform X2
sodium-coupled neutral amino acid transporter 9 isoform X3
DEAD-box helicase 4, transcript variant X1
DEAD-box helicase 4, transcript variant X3
DEAD-box helicase 4, transcript variant X2
DEAD-box helicase 4, transcript variant X4
probable ATP-dependent RNA helicase DDX4 isoform X1
probable ATP-dependent RNA helicase DDX4 isoform X3
probable ATP-dependent RNA helicase DDX4 isoform X2
probable ATP-dependent RNA helicase DDX4 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
interleukin 6 cytokine family signal transducer
ankyrin repeat domain 55, transcript variant X1
ankyrin repeat domain 55, transcript variant X2
ankyrin repeat domain-containing protein 55
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments
mitogen-activated protein kinase kinase kinase 1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 15% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: SET domain-containing protein 9
MIER family member 3, transcript variant X2
MIER family member 3, transcript variant X1
mesoderm induction early response protein 3 isoform X2
mesoderm induction early response protein 3 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 46% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC121822760, transcript variant X2
uncharacterized LOC121822760, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
GC-rich promoter binding protein 1, transcript variant X2
GC-rich promoter binding protein 1, transcript variant X1
GC-rich promoter binding protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
actin beta like 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 490 Proteins, and 37% coverage of the annotated genomic feature by RNAseq alignments
actin beta like 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 55% coverage of the annotated genomic feature by RNAseq alignments
GRB2 binding adaptor protein, transmembrane
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 4 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00554
RAB3C, member RAS oncogene family, transcript variant X2
RAB3C, member RAS oncogene family, transcript variant X1
phosphodiesterase 4D, transcript variant X3
phosphodiesterase 4D, transcript variant X1
phosphodiesterase 4D, transcript variant X4
phosphodiesterase 4D, transcript variant X5
phosphodiesterase 4D, transcript variant X6
phosphodiesterase 4D, transcript variant X2
phosphodiesterase 4D, transcript variant X7
phosphodiesterase 4D, transcript variant X8
phosphodiesterase 4D, transcript variant X13
phosphodiesterase 4D, transcript variant X11
phosphodiesterase 4D, transcript variant X12
phosphodiesterase 4D, transcript variant X10
phosphodiesterase 4D, transcript variant X9
cAMP-specific 3',5'-cyclic phosphodiesterase 4D isoform X3
cAMP-specific 3',5'-cyclic phosphodiesterase 4D isoform X1
cAMP-specific 3',5'-cyclic phosphodiesterase 4D isoform X4
cAMP-specific 3',5'-cyclic phosphodiesterase 4D isoform X5
cAMP-specific 3',5'-cyclic phosphodiesterase 4D isoform X6
cAMP-specific 3',5'-cyclic phosphodiesterase 4D isoform X2
cAMP-specific 3',5'-cyclic phosphodiesterase 4D isoform X7
cAMP-specific 3',5'-cyclic phosphodiesterase 4D isoform X8
cAMP-specific 3',5'-cyclic phosphodiesterase 4D isoform X10
cAMP-specific 3',5'-cyclic phosphodiesterase 4D isoform X9
cAMP-specific 3',5'-cyclic phosphodiesterase 4D isoform X11
COORDINATES: nucleotide motif:Rfam:12.0:RF00012
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
DEP domain containing 1B, transcript variant X2
DEP domain containing 1B, transcript variant X1
DEP domain containing 1B, transcript variant X3
DEP domain-containing protein 1B isoform X1
DEP domain-containing protein 1B isoform X2
ELOVL fatty acid elongase 7, transcript variant X1
ELOVL fatty acid elongase 7, transcript variant X2
elongation of very long chain fatty acids protein 7 isoform X1
elongation of very long chain fatty acids protein 7 isoform X2
uncharacterized LOC121822766, transcript variant X2
uncharacterized LOC121822766, transcript variant X1
ERCC excision repair 8, CSA ubiquitin ligase complex subunit, transcript variant X1
ERCC excision repair 8, CSA ubiquitin ligase complex subunit, transcript variant X4
ERCC excision repair 8, CSA ubiquitin ligase complex subunit, transcript variant X3
ERCC excision repair 8, CSA ubiquitin ligase complex subunit, transcript variant X5
ERCC excision repair 8, CSA ubiquitin ligase complex subunit, transcript variant X2
DNA excision repair protein ERCC-8 isoform X1
DNA excision repair protein ERCC-8 isoform X2
DNA excision repair protein ERCC-8 isoform X3
DNA excision repair protein ERCC-8 isoform X4
NADH:ubiquinone oxidoreductase complex assembly factor 2, transcript variant X1
NADH:ubiquinone oxidoreductase complex assembly factor 2, transcript variant X3
NADH:ubiquinone oxidoreductase complex assembly factor 2, transcript variant X2
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 2 isoform X3
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 2 isoform X1
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 2 isoform X2
small integral membrane protein 15, transcript variant X2
small integral membrane protein 15, transcript variant X3
small integral membrane protein 15, transcript variant X4
small integral membrane protein 15 isoform X2
small integral membrane protein 15, transcript variant X1
small integral membrane protein 15 isoform X1
uncharacterized LOC121822929, transcript variant X2
uncharacterized LOC121822929, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
zinc finger SWIM-type containing 6, transcript variant X3
zinc finger SWIM-type containing 6, transcript variant X2
zinc finger SWIM domain-containing protein 6 isoform X2
zinc finger SWIM-type containing 6, transcript variant X1
zinc finger SWIM domain-containing protein 6 isoform X1
zinc finger SWIM domain-containing protein 6 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 mRNAs, 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
uncharacterized LOC121822769, transcript variant X3
uncharacterized LOC121822769, transcript variant X2
uncharacterized LOC121822769, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
uncharacterized LOC121822933, transcript variant X2
uncharacterized LOC121822933, transcript variant X1
kinesin family member 2A, transcript variant X2
kinesin family member 2A, transcript variant X1
kinesin family member 2A, transcript variant X4
kinesin family member 2A, transcript variant X3
COORDINATES: nucleotide motif:Rfam:12.0:RF00494
COORDINATES: nucleotide motif:Rfam:12.0:RF00493
DIM1 rRNA methyltransferase and ribosome maturation factor, transcript variant X3
DIM1 rRNA methyltransferase and ribosome maturation factor, transcript variant X2
DIM1 rRNA methyltransferase and ribosome maturation factor, transcript variant X1
probable dimethyladenosine transferase isoform X2
probable dimethyladenosine transferase isoform X1
probable dimethyladenosine transferase isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
leucine-rich repeat-containing protein 70
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 8% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
ring finger protein 180, transcript variant X2
ring finger protein 180, transcript variant X1
ring finger protein 180, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
trifunctional nucleotide phosphoesterase protein YfkN-like, transcript variant X1
trifunctional nucleotide phosphoesterase protein YfkN-like, transcript variant X2
trifunctional nucleotide phosphoesterase protein YfkN-like isoform X1
trifunctional nucleotide phosphoesterase protein YfkN-like isoform X2
regulator of G protein signaling 7 binding protein, transcript variant X1
regulator of G protein signaling 7 binding protein, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 59 samples with support for all annotated introns
regulator of G-protein signaling 7-binding protein isoform X1
regulator of G-protein signaling 7-binding protein isoform X4
regulator of G protein signaling 7 binding protein, transcript variant X2
regulator of G-protein signaling 7-binding protein isoform X2
regulator of G protein signaling 7 binding protein, transcript variant X4
regulator of G protein signaling 7 binding protein, transcript variant X3
regulator of G-protein signaling 7-binding protein isoform X3
uncharacterized LOC121822774, transcript variant X2
uncharacterized LOC121822774, transcript variant X3
uncharacterized LOC121822774, transcript variant X1
transfer RNA glutamic acid (anticodon CUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
CWC27 spliceosome associated cyclophilin
spliceosome-associated protein CWC27 homolog
transfer RNA alanine (anticodon UGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 58% coverage of the annotated genomic feature by RNAseq alignments
ADAM metallopeptidase with thrombospondin type 1 motif 6, transcript variant X1
ADAM metallopeptidase with thrombospondin type 1 motif 6, transcript variant X3
ADAM metallopeptidase with thrombospondin type 1 motif 6, transcript variant X5
ADAM metallopeptidase with thrombospondin type 1 motif 6, transcript variant X4
ADAM metallopeptidase with thrombospondin type 1 motif 6, transcript variant X6
A disintegrin and metalloproteinase with thrombospondin motifs 6 isoform X1
A disintegrin and metalloproteinase with thrombospondin motifs 6 isoform X2
A disintegrin and metalloproteinase with thrombospondin motifs 6 isoform X3
A disintegrin and metalloproteinase with thrombospondin motifs 6 isoform X4
ADAM metallopeptidase with thrombospondin type 1 motif 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC102926626, transcript variant X1
uncharacterized LOC102926626, transcript variant X2
baculoviral IAP repeat-containing protein 1b-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
baculoviral IAP repeat-containing protein 1e-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
baculoviral IAP repeat-containing protein 1a-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC121822936, transcript variant X2
uncharacterized LOC121822936, transcript variant X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 60% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: gem-associated protein 7-like
heterogeneous nuclear ribonucleoprotein F-like
EGF like repeats and discoidin domains 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 72% coverage of the annotated genomic feature by RNAseq alignments
EGF like repeats and discoidin domains 3, transcript variant X1
EGF-like repeat and discoidin I-like domain-containing protein 3 isoform X1
EGF-like repeat and discoidin I-like domain-containing protein 3 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
hyaluronan and proteoglycan link protein 1, transcript variant X1
hyaluronan and proteoglycan link protein 1, transcript variant X2
hyaluronan and proteoglycan link protein 1
X-ray repair cross complementing 4, transcript variant X1
X-ray repair cross complementing 4, transcript variant X2
X-ray repair cross complementing 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 77% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF01233
uncharacterized LOC121822781, transcript variant X3
uncharacterized LOC121822781, transcript variant X1
uncharacterized LOC121822781, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 64% coverage of the annotated genomic feature by RNAseq alignments
V-type proton ATPase subunit S1-like protein, transcript variant X1
V-type proton ATPase subunit S1-like protein, transcript variant X2
V-type proton ATPase subunit S1-like protein, transcript variant X3
V-type proton ATPase subunit S1-like protein isoform X1
V-type proton ATPase subunit S1-like protein isoform X2
V-type proton ATPase subunit S1-like protein isoform X3
autophagy related 10, transcript variant X5
autophagy related 10, transcript variant X3
autophagy related 10, transcript variant X2
autophagy related 10, transcript variant X1
autophagy related 10, transcript variant X6
autophagy related 10, transcript variant X4
ubiquitin-like-conjugating enzyme ATG10 isoform X4
ubiquitin-like-conjugating enzyme ATG10 isoform X1
ubiquitin-like-conjugating enzyme ATG10 isoform X3
ubiquitin-like-conjugating enzyme ATG10 isoform X2
single stranded DNA binding protein 2, transcript variant X1
single stranded DNA binding protein 2, transcript variant X2
single stranded DNA binding protein 2, transcript variant X3
single stranded DNA binding protein 2, transcript variant X4
single-stranded DNA-binding protein 2 isoform X1
single-stranded DNA-binding protein 2 isoform X2
single-stranded DNA-binding protein 2 isoform X3
single-stranded DNA-binding protein 2 isoform X4
single stranded DNA binding protein 2, transcript variant X5
single-stranded DNA-binding protein 2 isoform X5
acyl-CoA thioesterase 12, transcript variant X2
acetyl-coenzyme A thioesterase isoform X2
acyl-CoA thioesterase 12, transcript variant X1
acetyl-coenzyme A thioesterase isoform X1
zinc finger CCHC-type containing 9, transcript variant X1
zinc finger CCHC-type containing 9, transcript variant X2
zinc finger CCHC domain-containing protein 9
Ras protein specific guanine nucleotide releasing factor 2, transcript variant X5
Ras protein specific guanine nucleotide releasing factor 2, transcript variant X2
Ras protein specific guanine nucleotide releasing factor 2, transcript variant X1
Ras protein specific guanine nucleotide releasing factor 2, transcript variant X4
Ras protein specific guanine nucleotide releasing factor 2, transcript variant X3
ras-specific guanine nucleotide-releasing factor 2 isoform X5
ras-specific guanine nucleotide-releasing factor 2 isoform X4
ras-specific guanine nucleotide-releasing factor 2 isoform X2
ras-specific guanine nucleotide-releasing factor 2 isoform X3
ras-specific guanine nucleotide-releasing factor 2 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 5 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 mRNAs, 5 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 55 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 5 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 5 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 5 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 5 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
DNA mismatch repair protein Msh3 isoform X4
DNA mismatch repair protein Msh3 isoform X3
DNA mismatch repair protein Msh3 isoform X2
DNA mismatch repair protein Msh3 isoform X1
DNA mismatch repair protein Msh3 isoform X5
DNA mismatch repair protein Msh3 isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
ankyrin repeat domain-containing protein 34B
family with sequence similarity 151 member B
zinc finger FYVE-type containing 16, transcript variant X3
zinc finger FYVE-type containing 16, transcript variant X4
zinc finger FYVE-type containing 16, transcript variant X1
zinc finger FYVE-type containing 16, transcript variant X2
zinc finger FYVE domain-containing protein 16 isoform X2
zinc finger FYVE domain-containing protein 16 isoform X1
serine incorporator 5, transcript variant X2
serine incorporator 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
uncharacterized LOC121822786, transcript variant X2
uncharacterized LOC121822786, transcript variant X1
terminal nucleotidyltransferase 2, transcript variant X2
terminal nucleotidyltransferase 2, transcript variant X4
terminal nucleotidyltransferase 2, transcript variant X1
terminal nucleotidyltransferase 2, transcript variant X6
terminal nucleotidyltransferase 2, transcript variant X5
terminal nucleotidyltransferase 2, transcript variant X3
terminal nucleotidyltransferase 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
homer scaffold protein 1, transcript variant X1
homer scaffold protein 1, transcript variant X2
homer scaffold protein 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
homer scaffold protein 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
homer scaffold protein 1, transcript variant X3
junction mediating and regulatory protein, p53 cofactor
junction-mediating and -regulatory protein
uncharacterized LOC121822789, transcript variant X2
uncharacterized LOC121822789, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
betaine--homocysteine S-methyltransferase, transcript variant X1
betaine--homocysteine S-methyltransferase, transcript variant X2
betaine--homocysteine S-methyltransferase 1 isoform X1
betaine--homocysteine S-methyltransferase 1 isoform X2
betaine--homocysteine S-methyltransferase 2, transcript variant X2
betaine--homocysteine S-methyltransferase 2, transcript variant X1
S-methylmethionine--homocysteine S-methyltransferase BHMT2 isoform X1
S-methylmethionine--homocysteine S-methyltransferase BHMT2 isoform X2
dimethylglycine dehydrogenase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
dimethylglycine dehydrogenase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
dimethylglycine dehydrogenase, mitochondrial isoform X2
dimethylglycine dehydrogenase, mitochondrial isoform X3
dimethylglycine dehydrogenase, transcript variant X1
dimethylglycine dehydrogenase, mitochondrial isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 mRNAs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00399
LHFPL tetraspan subfamily member 2, transcript variant X1
LHFPL tetraspan subfamily member 2, transcript variant X2
LHFPL tetraspan subfamily member 2 protein
secretory carrier membrane protein 1, transcript variant X2
secretory carrier membrane protein 1, transcript variant X6
secretory carrier membrane protein 1, transcript variant X3
secretory carrier membrane protein 1, transcript variant X1
secretory carrier membrane protein 1, transcript variant X5
secretory carrier membrane protein 1, transcript variant X4
secretory carrier-associated membrane protein 1 isoform X2
secretory carrier-associated membrane protein 1 isoform X1
adaptor related protein complex 3 subunit beta 1, transcript variant X2
adaptor related protein complex 3 subunit beta 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins
phosphodiesterase 8B, transcript variant X7
phosphodiesterase 8B, transcript variant X6
phosphodiesterase 8B, transcript variant X2
phosphodiesterase 8B, transcript variant X4
phosphodiesterase 8B, transcript variant X1
phosphodiesterase 8B, transcript variant X5
phosphodiesterase 8B, transcript variant X3
high affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B isoform X7
high affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B isoform X6
high affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B isoform X5
high affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B isoform X2
high affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B isoform X4
high affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B isoform X3
high affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B isoform X1
uncharacterized LOC121822800, transcript variant X2
uncharacterized LOC121822800, transcript variant X1
COORDINATES: nucleotide motif:Rfam:12.0:RF01234
zinc finger BED domain-containing protein 3
angiogenic factor with G-patch and FHA domains 1
angiogenic factor with G patch and FHA domains 1
uncharacterized LOC121822802, transcript variant X5
uncharacterized LOC121822802, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC121822802, transcript variant X7
uncharacterized LOC121822802, transcript variant X6
uncharacterized LOC121822802, transcript variant X1
uncharacterized LOC121822802, transcript variant X10
uncharacterized LOC121822802, transcript variant X4
uncharacterized LOC121822802, transcript variant X12
uncharacterized LOC121822802, transcript variant X11
uncharacterized LOC121822802, transcript variant X9
uncharacterized LOC121822802, transcript variant X3
uncharacterized LOC121822802, transcript variant X13
uncharacterized LOC121822802, transcript variant X8
corticotropin releasing hormone binding protein
corticotropin-releasing factor-binding protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 7 Proteins, and 40% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC121822804, transcript variant X1
uncharacterized LOC121822804, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 52% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: proteinase-activated receptor 1
IQ motif containing GTPase activating protein 2, transcript variant X2
IQ motif containing GTPase activating protein 2, transcript variant X1
IQ motif containing GTPase activating protein 2, transcript variant X3
ras GTPase-activating-like protein IQGAP2 isoform X2
ras GTPase-activating-like protein IQGAP2 isoform X1
ras GTPase-activating-like protein IQGAP2 isoform X3
coagulation factor II thrombin receptor like 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
synaptic vesicle glycoprotein 2C, transcript variant X1
synaptic vesicle glycoprotein 2C, transcript variant X2
POC5 centriolar protein, transcript variant X1
POC5 centriolar protein, transcript variant X2
POC5 centriolar protein, transcript variant X3
DNA polymerase kappa, transcript variant X7
DNA polymerase kappa, transcript variant X6
DNA polymerase kappa, transcript variant X5
DNA polymerase kappa, transcript variant X4
DNA polymerase kappa, transcript variant X1
DNA polymerase kappa, transcript variant X3
DNA polymerase kappa, transcript variant X2
DNA polymerase kappa, transcript variant X8
ceramide transporter 1, transcript variant X1
ceramide transporter 1, transcript variant X2
3-hydroxy-3-methylglutaryl-CoA reductase, transcript variant X3
3-hydroxy-3-methylglutaryl-CoA reductase, transcript variant X1
3-hydroxy-3-methylglutaryl-CoA reductase, transcript variant X2
3-hydroxy-3-methylglutaryl-Coenzyme A reductase
uncharacterized LOC121822806, transcript variant X2
uncharacterized LOC121822806, transcript variant X1
ankyrin repeat domain 31, transcript variant X1
ankyrin repeat domain 31, transcript variant X3
ankyrin repeat domain 31, transcript variant X4
ankyrin repeat domain 31, transcript variant X2
ankyrin repeat domain 31, transcript variant X5
ankyrin repeat domain 31, transcript variant X6
ankyrin repeat domain-containing protein 31 isoform X1
ankyrin repeat domain-containing protein 31 isoform X3
ankyrin repeat domain-containing protein 31 isoform X4
ankyrin repeat domain-containing protein 31 isoform X2
ankyrin repeat domain-containing protein 31 isoform X5
ankyrin repeat domain-containing protein 31 isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 77% coverage of the annotated genomic feature by RNAseq alignments
glucosaminyl (N-acetyl) transferase 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
glucosaminyl (N-acetyl) transferase 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
glucosaminyl (N-acetyl) transferase 4, transcript variant X2
glucosaminyl (N-acetyl) transferase 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 4 isoform X1
beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 4 isoform X2
uncharacterized LOC121822809, transcript variant X2
uncharacterized LOC121822809, transcript variant X1
family with sequence similarity 169 member A, transcript variant X2
family with sequence similarity 169 member A, transcript variant X1
soluble lamin-associated protein of 75 kDa
ribosome biogenesis protein NSA2 homolog
GTP dependent ribosome recycling factor mitochondrial 2, transcript variant X2
GTP dependent ribosome recycling factor mitochondrial 2, transcript variant X1
GTP dependent ribosome recycling factor mitochondrial 2, transcript variant X3
GTP dependent ribosome recycling factor mitochondrial 2, transcript variant X4
ribosome-releasing factor 2, mitochondrial isoform X1
ribosome-releasing factor 2, mitochondrial isoform X2
GTP dependent ribosome recycling factor mitochondrial 2, transcript variant X5
ribosome-releasing factor 2, mitochondrial isoform X3
ectodermal-neural cortex 1, transcript variant X1
ectodermal-neural cortex 1, transcript variant X2
uncharacterized LOC121822941, transcript variant X2
uncharacterized LOC121822941, transcript variant X1
uncharacterized LOC121822812, transcript variant X1
uncharacterized LOC121822812, transcript variant X3
uncharacterized LOC121822812, transcript variant X2
uncharacterized LOC121822814, transcript variant X3
uncharacterized LOC121822814, transcript variant X2
uncharacterized LOC121822814, transcript variant X1
uncharacterized LOC121822943, transcript variant X1
uncharacterized LOC121822943, transcript variant X2
Rho guanine nucleotide exchange factor 28, transcript variant X4
Rho guanine nucleotide exchange factor 28, transcript variant X2
Rho guanine nucleotide exchange factor 28, transcript variant X3
Rho guanine nucleotide exchange factor 28, transcript variant X1
Rho guanine nucleotide exchange factor 28, transcript variant X5
Rho guanine nucleotide exchange factor 28, transcript variant X6
rho guanine nucleotide exchange factor 28 isoform X2
rho guanine nucleotide exchange factor 28 isoform X3
rho guanine nucleotide exchange factor 28 isoform X1
rho guanine nucleotide exchange factor 28 isoform X4
rho guanine nucleotide exchange factor 28 isoform X5
rho guanine nucleotide exchange factor 28 isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 15% coverage of the annotated genomic feature by RNAseq alignments
UTP15 small subunit processome component, transcript variant X1
UTP15 small subunit processome component, transcript variant X2
UTP15 small subunit processome component, transcript variant X3
U3 small nucleolar RNA-associated protein 15 homolog
ankyrin repeat family A member 2, transcript variant X5
ankyrin repeat family A member 2, transcript variant X4
ankyrin repeat family A member 2, transcript variant X3
ankyrin repeat family A member 2, transcript variant X2
ankyrin repeat family A member 2, transcript variant X1
ankyrin repeat family A protein 2 isoform X1
ankyrin repeat family A protein 2 isoform X2
ankyrin repeat family A member 2, transcript variant X6
ankyrin repeat family A protein 2 isoform X3
low-density lipoprotein receptor class A domain-containing protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 Proteins, and 20% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
transmembrane protein 171, transcript variant X2
transmembrane protein 171, transcript variant X1
uncharacterized LOC121822818, transcript variant X2
uncharacterized LOC121822818, transcript variant X1
FCH and mu domain containing endocytic adaptor 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 68% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 80% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC121822820, transcript variant X3
uncharacterized LOC121822820, transcript variant X1
uncharacterized LOC121822820, transcript variant X2
zinc finger protein 366, transcript variant X2
zinc finger protein 366, transcript variant X1
uncharacterized LOC121822823, transcript variant X3
uncharacterized LOC121822823, transcript variant X2
uncharacterized LOC121822823, transcript variant X1
pentatricopeptide repeat domain 2, transcript variant X1
pentatricopeptide repeat domain 2, transcript variant X3
pentatricopeptide repeat-containing protein 2, mitochondrial isoform X1
pentatricopeptide repeat-containing protein 2, mitochondrial isoform X2
pentatricopeptide repeat domain 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
mitochondrial ribosomal protein S27, transcript variant X1
mitochondrial ribosomal protein S27, transcript variant X2
28S ribosomal protein S27, mitochondrial isoform X1
28S ribosomal protein S27, mitochondrial isoform X2
uncharacterized LOC121822824, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
uncharacterized LOC121822824, transcript variant X3
uncharacterized LOC121822824, transcript variant X4
uncharacterized LOC121822824, transcript variant X2
CART prepropeptide, transcript variant X1
CART prepropeptide, transcript variant X2
cocaine- and amphetamine-regulated transcript protein isoform X2
cocaine- and amphetamine-regulated transcript protein isoform X1
methylcrotonyl-CoA carboxylase subunit 2
methylcrotonoyl-CoA carboxylase beta chain, mitochondrial
B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB, transcript variant X2
B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB, transcript variant X3
B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB, transcript variant X1
transcription factor TFIIIB component B'' homolog isoform X2
transcription factor TFIIIB component B'' homolog isoform X3
transcription factor TFIIIB component B'' homolog isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
small EDRK-rich factor 1A, transcript variant X1
small EDRK-rich factor 1A, transcript variant X4
small EDRK-rich factor 1A, transcript variant X2
small EDRK-rich factor 1A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
sperm motility kinase 2B-like, transcript variant X1
sperm motility kinase 2B-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
sperm motility kinase 2B-like, transcript variant X2
sperm motility kinase 2B-like, transcript variant X4
centromere protein K, transcript variant X2
centromere protein K, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins
peptidylprolyl isomerase domain and WD repeat containing 1, transcript variant X1
peptidylprolyl isomerase domain and WD repeat-containing protein 1 isoform X1
peptidylprolyl isomerase domain and WD repeat containing 1, transcript variant X2
peptidylprolyl isomerase domain and WD repeat-containing protein 1 isoform X2
shieldin complex subunit 3, transcript variant X1
trafficking protein particle complex subunit 13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 92 samples with support for all annotated introns
shieldin complex subunit 3, transcript variant X2
small glutamine rich tetratricopeptide repeat co-chaperone beta
small glutamine-rich tetratricopeptide repeat-containing protein beta
erbb2 interacting protein, transcript variant X2
erbb2 interacting protein, transcript variant X7
erbb2 interacting protein, transcript variant X5
erbb2 interacting protein, transcript variant X3
erbb2 interacting protein, transcript variant X8
erbb2 interacting protein, transcript variant X9
erbb2 interacting protein, transcript variant X1
erbb2 interacting protein, transcript variant X6
erbb2 interacting protein, transcript variant X4
splicing regulatory glutamic acid and lysine rich protein 1, transcript variant X1
splicing regulatory glutamic acid and lysine rich protein 1, transcript variant X2
splicing regulatory glutamine/lysine-rich protein 1 isoform X1
splicing regulatory glutamine/lysine-rich protein 1 isoform X2
splicing regulatory glutamic acid and lysine rich protein 1, transcript variant X4
splicing regulatory glutamic acid and lysine rich protein 1, transcript variant X3
splicing regulatory glutamic acid and lysine rich protein 1, transcript variant X5
splicing regulatory glutamine/lysine-rich protein 1 isoform X3
splicing regulatory glutamine/lysine-rich protein 1 isoform X4
H/ACA ribonucleoprotein complex subunit 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
microtubule associated serine/threonine kinase family member 4, transcript variant X1
microtubule associated serine/threonine kinase family member 4, transcript variant X3
microtubule associated serine/threonine kinase family member 4, transcript variant X6
microtubule associated serine/threonine kinase family member 4, transcript variant X2
microtubule associated serine/threonine kinase family member 4, transcript variant X7
microtubule associated serine/threonine kinase family member 4, transcript variant X4
microtubule associated serine/threonine kinase family member 4, transcript variant X5
microtubule associated serine/threonine kinase family member 4, transcript variant X8
microtubule-associated serine/threonine-protein kinase 4 isoform X1
microtubule-associated serine/threonine-protein kinase 4 isoform X6
microtubule-associated serine/threonine-protein kinase 4 isoform X2
microtubule-associated serine/threonine-protein kinase 4 isoform X7
microtubule-associated serine/threonine-protein kinase 4 isoform X3
microtubule-associated serine/threonine-protein kinase 4 isoform X4
microtubule-associated serine/threonine-protein kinase 4 isoform X5
microtubule-associated serine/threonine-protein kinase 4 isoform X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 34% coverage of the annotated genomic feature by RNAseq alignments
microtubule associated serine/threonine kinase family member 4, transcript variant X11
microtubule associated serine/threonine kinase family member 4, transcript variant X14
microtubule associated serine/threonine kinase family member 4, transcript variant X9
microtubule-associated serine/threonine-protein kinase 4 isoform X9
microtubule-associated serine/threonine-protein kinase 4 isoform X11
microtubule-associated serine/threonine-protein kinase 4 isoform X14
microtubule associated serine/threonine kinase family member 4, transcript variant X10
microtubule associated serine/threonine kinase family member 4, transcript variant X15
microtubule-associated serine/threonine-protein kinase 4 isoform X10
microtubule-associated serine/threonine-protein kinase 4 isoform X15
microtubule associated serine/threonine kinase family member 4, transcript variant X12
microtubule associated serine/threonine kinase family member 4, transcript variant X13
microtubule associated serine/threonine kinase family member 4, transcript variant X16
microtubule-associated serine/threonine-protein kinase 4 isoform X12
microtubule-associated serine/threonine-protein kinase 4 isoform X13
microtubule-associated serine/threonine-protein kinase 4 isoform X16
phosphoinositide-3-kinase regulatory subunit 1, transcript variant X1
phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1
uncharacterized LOC121822836, transcript variant X2
uncharacterized LOC121822836, transcript variant X1
phosphoinositide-3-kinase regulatory subunit 1, transcript variant X3
phosphatidylinositol 3-kinase regulatory subunit alpha isoform X3
phosphoinositide-3-kinase regulatory subunit 1, transcript variant X2
phosphatidylinositol 3-kinase regulatory subunit alpha isoform X2
uncharacterized LOC121822838, transcript variant X5
uncharacterized LOC121822838, transcript variant X6
uncharacterized LOC121822838, transcript variant X7
uncharacterized LOC121822838, transcript variant X3
uncharacterized LOC121822838, transcript variant X4
uncharacterized LOC121822838, transcript variant X8
uncharacterized LOC121822838, transcript variant X2
uncharacterized LOC121822838, transcript variant X1
uncharacterized LOC121822839, transcript variant X1
uncharacterized LOC121822839, transcript variant X2
uncharacterized LOC121822840, transcript variant X2
uncharacterized LOC121822840, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 33% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 81% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC107401915, transcript variant X4
uncharacterized LOC107401915, transcript variant X2
uncharacterized LOC107401915, transcript variant X1
uncharacterized LOC107401915, transcript variant X3
G2/mitotic-specific cyclin-B1 isoform X1
G2/mitotic-specific cyclin-B1 isoform X2
mitochondrial ribosomal protein S36, transcript variant X2
28S ribosomal protein S36, mitochondrial isoform X2
mitochondrial ribosomal protein S36, transcript variant X1
28S ribosomal protein S36, mitochondrial isoform X1
cyclin dependent kinase 7, transcript variant X4
cyclin dependent kinase 7, transcript variant X3
cyclin dependent kinase 7, transcript variant X2
cyclin dependent kinase 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 48% coverage of the annotated genomic feature by RNAseq alignments
coiled-coil domain containing 125, transcript variant X7
coiled-coil domain containing 125, transcript variant X6
coiled-coil domain containing 125, transcript variant X4
coiled-coil domain containing 125, transcript variant X3
coiled-coil domain containing 125, transcript variant X5
coiled-coil domain containing 125, transcript variant X1
coiled-coil domain containing 125, transcript variant X2
coiled-coil domain-containing protein 125
TATA-box binding protein associated factor 9
transcription initiation factor TFIID subunit 9
RAD17 checkpoint clamp loader component, transcript variant X2
RAD17 checkpoint clamp loader component, transcript variant X1
MARVEL domain containing 2, transcript variant X2
MARVEL domain containing 2, transcript variant X1
general transcription factor IIH subunit 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 7% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 21% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
cytochrome c oxidase subunit 7C, mitochondrial
COORDINATES: nucleotide motif:Rfam:12.0:RF00341
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 49% coverage of the annotated genomic feature by RNAseq alignments
transmembrane protein 161B, transcript variant X3
transmembrane protein 161B, transcript variant X1
transmembrane protein 161B, transcript variant X4
transmembrane protein 161B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 33% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC121822853, transcript variant X2
uncharacterized LOC121822853, transcript variant X1
myocyte enhancer factor 2C, transcript variant X2
myocyte enhancer factor 2C, transcript variant X7
myocyte enhancer factor 2C, transcript variant X5
myocyte enhancer factor 2C, transcript variant X12
myocyte enhancer factor 2C, transcript variant X10
myocyte enhancer factor 2C, transcript variant X11
myocyte enhancer factor 2C, transcript variant X13
myocyte enhancer factor 2C, transcript variant X6
myocyte enhancer factor 2C, transcript variant X1
myocyte enhancer factor 2C, transcript variant X9
myocyte enhancer factor 2C, transcript variant X8
myocyte enhancer factor 2C, transcript variant X4
myocyte enhancer factor 2C, transcript variant X3
myocyte-specific enhancer factor 2C isoform X9
myocyte-specific enhancer factor 2C isoform X10
myocyte-specific enhancer factor 2C isoform X8
myocyte-specific enhancer factor 2C isoform X7
myocyte-specific enhancer factor 2C isoform X4
myocyte-specific enhancer factor 2C isoform X2
myocyte-specific enhancer factor 2C isoform X6
myocyte-specific enhancer factor 2C isoform X3
myocyte-specific enhancer factor 2C isoform X5
myocyte-specific enhancer factor 2C isoform X1
uncharacterized LOC121822856, transcript variant X2
uncharacterized LOC121822856, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC121822856, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC107402793, transcript variant X4
uncharacterized LOC107402793, transcript variant X3
uncharacterized LOC107402793, transcript variant X2
uncharacterized LOC107402793, transcript variant X1
uncharacterized LOC121822859, transcript variant X3
uncharacterized LOC121822859, transcript variant X2
uncharacterized LOC121822859, transcript variant X1
metallo-beta-lactamase domain containing 2
metallo-beta-lactamase domain-containing protein 2
RNA polymerase III subunit G, transcript variant X1
RNA polymerase III subunit G, transcript variant X2
DNA-directed RNA polymerase III subunit RPC7
lysM and putative peptidoglycan-binding domain-containing protein 3
arrestin domain containing 3, transcript variant X1
arrestin domain-containing protein 3 isoform X1
arrestin domain containing 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 60 samples with support for all annotated introns
arrestin domain-containing protein 3 isoform X2
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC121822861, transcript variant X2
uncharacterized LOC121822861, transcript variant X1
nuclear receptor subfamily 2 group F member 1
family with sequence similarity 172 member A, transcript variant X1
family with sequence similarity 172 member A, transcript variant X3
family with sequence similarity 172 member A, transcript variant X4
family with sequence similarity 172 member A, transcript variant X5
cotranscriptional regulator FAM172A isoform X3
cotranscriptional regulator FAM172A isoform X4
cotranscriptional regulator FAM172A isoform X1
cotranscriptional regulator FAM172A isoform X5
POU domain class 5, transcription factor 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 2 ESTs, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
POU domain, class 5, transcription factor 2
family with sequence similarity 172 member A, transcript variant X2
cotranscriptional regulator FAM172A isoform X2
uncharacterized LOC121822863, transcript variant X3
uncharacterized LOC121822863, transcript variant X4
uncharacterized LOC121822863, transcript variant X2
uncharacterized LOC121822863, transcript variant X1
uncharacterized LOC121822863, transcript variant X6
uncharacterized LOC121822863, transcript variant X5
KIAA0825 ortholog, transcript variant X3
KIAA0825 ortholog, transcript variant X1
KIAA0825 ortholog, transcript variant X4
uncharacterized protein KIAA0825 homolog isoform X3
uncharacterized protein KIAA0825 homolog isoform X1
uncharacterized protein KIAA0825 homolog isoform X4
KIAA0825 ortholog, transcript variant X2
uncharacterized protein KIAA0825 homolog isoform X2
KIAA0825 ortholog, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized protein KIAA0825 homolog isoform X5
KIAA0825 ortholog, transcript variant X6
uncharacterized protein KIAA0825 homolog isoform X6
SMC5-SMC6 complex localization factor 1, transcript variant X1
SMC5-SMC6 complex localization factor 1, transcript variant X2
SMC5-SMC6 complex localization factor 1, transcript variant X4
SMC5-SMC6 complex localization factor 1, transcript variant X3
SMC5-SMC6 complex localization factor protein 1
multiple C2 and transmembrane domain containing 1, transcript variant X8
multiple C2 and transmembrane domain containing 1, transcript variant X6
multiple C2 and transmembrane domain containing 1, transcript variant X10
multiple C2 and transmembrane domain containing 1, transcript variant X3
multiple C2 and transmembrane domain containing 1, transcript variant X5
multiple C2 and transmembrane domain containing 1, transcript variant X2
multiple C2 and transmembrane domain containing 1, transcript variant X4
multiple C2 and transmembrane domain containing 1, transcript variant X1
multiple C2 and transmembrane domain containing 1, transcript variant X9
multiple C2 and transmembrane domain containing 1, transcript variant X7
multiple C2 and transmembrane domain containing 1, transcript variant X11
multiple C2 and transmembrane domain containing 1, transcript variant X12
multiple C2 and transmembrane domain containing 1, transcript variant X13
multiple C2 and transmembrane domain-containing protein 1 isoform X9
multiple C2 and transmembrane domain-containing protein 1 isoform X6
multiple C2 and transmembrane domain-containing protein 1 isoform X7
multiple C2 and transmembrane domain-containing protein 1 isoform X3
multiple C2 and transmembrane domain-containing protein 1 isoform X5
multiple C2 and transmembrane domain-containing protein 1 isoform X2
multiple C2 and transmembrane domain-containing protein 1 isoform X4
multiple C2 and transmembrane domain-containing protein 1 isoform X1
multiple C2 and transmembrane domain-containing protein 1 isoform X13
multiple C2 and transmembrane domain-containing protein 1 isoform X12
multiple C2 and transmembrane domain-containing protein 1 isoform X11
multiple C2 and transmembrane domain-containing protein 1 isoform X10
multiple C2 and transmembrane domain-containing protein 1 isoform X8
multiple C2 and transmembrane domain containing 1, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
multiple C2 and transmembrane domain-containing protein 1 isoform X14
interferon-induced transmembrane protein 3-like
family with sequence similarity 81 member B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
tetratricopeptide repeat domain 37, transcript variant X1
tetratricopeptide repeat domain 37, transcript variant X4
tetratricopeptide repeat domain 37, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
tetratricopeptide repeat domain 37, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
tetratricopeptide repeat domain 37, transcript variant X5
tetratricopeptide repeat protein 37 isoform X2
tetratricopeptide repeat protein 37 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 79% coverage of the annotated genomic feature by RNAseq alignments
Rieske Fe-S domain containing, transcript variant X6
Rieske Fe-S domain containing, transcript variant X5
Rieske Fe-S domain containing, transcript variant X1
Rieske Fe-S domain containing, transcript variant X2
Rieske Fe-S domain containing, transcript variant X4
Rieske Fe-S domain containing, transcript variant X3
Rieske domain-containing protein isoform X1
Rieske domain-containing protein isoform X2
Rieske domain-containing protein isoform X3
spermatogenesis associated 9, transcript variant X2
spermatogenesis associated 9, transcript variant X1
spermatogenesis associated 9, transcript variant X3
spermatogenesis-associated protein 9 isoform X1
spermatogenesis-associated protein 9 isoform X2
spermatogenesis-associated protein 9 isoform X3
rho-related BTB domain-containing protein 3
COORDINATES: nucleotide motif:Rfam:12.0:RF00056
elongation factor for RNA polymerase II 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 78 samples with support for all annotated introns
RNA polymerase II elongation factor ELL2
uncharacterized LOC121822867, transcript variant X2
uncharacterized LOC121822867, transcript variant X1
proprotein convertase subtilisin/kexin type 1
uncharacterized LOC121822869, transcript variant X1
uncharacterized LOC121822869, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 71% coverage of the annotated genomic feature by RNAseq alignments
endoplasmic reticulum aminopeptidase 1, transcript variant X2
endoplasmic reticulum aminopeptidase 1, transcript variant X3
endoplasmic reticulum aminopeptidase 1, transcript variant X1
endoplasmic reticulum aminopeptidase 1 isoform X2
endoplasmic reticulum aminopeptidase 1 isoform X1